Researchers have identified a new type of visual cell in deep-sea fish larvae that challenges a century of knowledge about ...
When a cell divides, it performs a feat of microscopic choreography—duplicating its DNA and depositing it into two new cells.
There is no meaningful difference between a cell phone signal booster and a mobile signal booster. They are two ways of ...
By Padmanabhan Ananthan and Sriparna Roy Feb 9 (Reuters) - Eli Lilly will buy Orna Therapeutics for up to $2.4 billion in ...
News-Medical.Net on MSN
Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study
By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...
Grew Solar has raised ₹1,050 crore in funding to expand its solar cell manufacturing capacity from 3 GW to 8 GW, enhancing ...
Explore how community blood centers are shaping the future of cell and gene therapies, from customized collections to ...
A new study, recently published in the journal Nature Communications, is leading to a new understanding of how immune cells ...
Eli Lilly (LLY) stock acquiring Orna Therapeutics for up to $2.4 billion to develop circular RNA CAR-T therapies for B ...
Pharmaceutical Technology on MSN
Eli Lilly bets on in vivo cell therapy in $2.4bn Orna Therapeutics buyout
Lilly joins the growing list of big pharma companies hoping to see success from their acquired in vivo CAR-T programmes.
Chinese scientists’ research could open new doors for ‘precision-targeted’ treatment of the most common form of dementia.
CAR T-cell therapy, considered one of the most promising breakthroughs in cancer treatment, works by harnessing the patient’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results